OptimizeRx Q4 Adj. EPS $0.51 Beats $0.23 Estimate, Sales $32.200M Beat $31.100M Estimate
Benzinga Newsdesk 8 months ago
EarningsEarnings BeatsNews
OptimizeRx (NASDAQ:OPRX) reported quarterly earnings of $0.51 per share which beat the analyst consensus estimate of $0.23 by 124.67 percent. This is a 70 percent increase over earnings of $0.30 per share from the same
OptimizeRx (NASDAQ:OPRX) reported quarterly earnings of $0.51 per share which beat the analyst consensus estimate of $0.23 by 124.67 percent. This is a 70 percent increase over earnings of $0.30 per share from the same period last year. The company reported quarterly sales of $32.200 million which beat the analyst consensus estimate of $31.100 million by 3.54 percent. This is a 0.36 percent decrease over sales of $32.317 million the same period last year.